Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Valeant's New Strategic Direction: Clean Break Or Simply A Paint Job?

Executive Summary

Trying to get out from under the shadow of ongoing investigations into its pricing and questionable business practices, which have led to its shares diving 90% in the past year, Valeant Pharmaceuticals International Inc. laid out its strategy for becoming a "new" company. But one analyst questioned whether the changes being made were simply "new paint on the same old shed."

Advertisement

Related Content

Valeant On Track With Debt-Reduction Goals, But Will It Be Enough?
Debt-laden Valeant Sells Its Assets, More Divestments Likely
Valeant Is Weighing Offers For Assets As Stocks Plunges Again
3Q Pharma Results Preview: Pfizer, Gilead, Allergan, Valeant, AstraZeneca
Stockwatch: Landscaping Earnings Announcements At Valeant And Endo
Valeant's Dermatology Sales Strategy: Teenage Zits
Valeant’s Oral Relistor Poised To Face-Off Against AstraZeneca’s Movantik
Valeant Reset: Will It Cure What Ails It?
Valeant: Seeking Disaster Expert To Run A Hot Mess
Valeant: Another Fine Mess

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097092

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel